Open Access
Issue
BIO Web Conf.
Volume 100, 2024
International Scientific Forum “Modern Trends in Sustainable Development of Biological Sciences” (IFBioScFU 2024)
Article Number 01017
Number of page(s) 7
Section Interdisciplinary Research in Biophysics, Biomedicine, and Neuroscience
DOI https://doi.org/10.1051/bioconf/202410001017
Published online 08 April 2024
  • T. Aziz, L. Ali, T. Ansari, H. B. Liaquat, S. Shah, J. Ara, Pancytopenia: Megaloblastic anemia is still the commonest cause. Pak J Med Sci, 26 (1), 132–136 (2010). https://www.banglajol.info/index.php/JDMC/article/view/38835 [Google Scholar]
  • Sanchez-Ramon, Silvia & Bermúdez, Arancha & Gonzalez-Granado, Luis & Rodriguez-Gallego, Carlos & Sastre, Ana & Soler-Palacín, Pere. (2019). Primary and Secondary Immunodeficiency Diseases in Oncohaematology: Warning Signs, Diagnosis, and Management. Frontiers in Immunology. 10. 586. 10.3389/fimmu.2019.00586. [CrossRef] [Google Scholar]
  • C. J. Logothetis, M. L. Samuel, A. C. von Eschenbach, A. Trindade, S. Ogden, C. Grant, D. E. Johnson, Doxorubicin, mitomycin-C, and 5-fluorouracil (DMF) in the treatment of metastatic hormonal refractory adenocarcinoma of the prostate, with a note on the staging of metastatic prostate cancer. J. Clin. Oncol., 1 (6), 368–379 (1983). https://doi.org/10.1200/JCO.1983.1.6.368 [CrossRef] [PubMed] [Google Scholar]
  • Thwaites R.S., Sanchez Sevilla Uruchurtu, A., Siggins M.K., Liew, F., Russell C.D., Moore S.C., Fairfield C., Carter E., Abrams S., Short C.E., Thaventhiran T., Bergstrom E., Gardener Z., Ascough S., Chiu C., Docherty A.B., Hunt D., Crow Y.J., Solomon T., Taylor G.P., Turtle L., Harrison E.M., Dunning J., Semple M.G., Baillie J.K., Openshaw P.J.; ISARIC4C investigators. Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19. Sci Immunol. 6(57), eabg9873 (2021) DOI: 10.1126/sciimmunol.abg9873. PMID: 33692097. [CrossRef] [Google Scholar]
  • K. Das Makheja, B. Kumar Maheshwari, S. Arain, S. Kumar, S. Kumari, The common causes leading to pancytopenia in patients presenting to tertiary care hospital. Pak J Med Sci., 29 (5), 1108–1111 (2013). https://pjms.com.pk/index.php/pjms/article/view/3458/1711 [Google Scholar]
  • Order of the Minister of Health Care of the Republic of Kazakhstan from November 4, 2020 No. KR DSM-181/2020 (“On approval of the rules for the assessment of materials and compliance of preclinical (non-clinical) studies with Good Laboratory Practice (GLP) requirements of the Republic of Kazakhstan and/or the Eurasian Economic Union within the framework of pharmaceutical inspection.” Registered with the Ministry of Justice of the Republic of Kazakhstan on November 5, 2020 under No. 21596. Available at: https://adilet.zan.kz/eng/docs/V2000021596 [Google Scholar]
  • Y. Hirakata, N. Furuya, K. Tateda, K. Yamaguchi, A protective role for lymphocytes in cyclophosphamide induced endogenous bacteraemia in mice. J. Med. Microbiol, 43 (2), 141–147 (1995). https://doi.org/10.1099/00222615-43-2-141 [Google Scholar]
  • Y. Motoyoshi, K. Kaminoda, O. Saitoh, K. Hamasaki, K. Nakao, N. Ishii, Y. Nagayama, K. Eguchi, Different mechanisms for anti-tumor effects of low- and high-dose cyclophosphamide. Oncol. Rep, 16 (1), 141–146 (2006). https://doi.org/10.3892/or.16.1.141 [Google Scholar]
  • L. Xu, W. Xu, Z. Jiang, F. Zhang, Y. Chu, and S. Xiong, Depletion of CD4+CD25high regulatory T cells from tumor infiltrating lymphocytes predominantly induces Th1 type immune response in vivo which inhibits tumor growth in adoptive immunotherapy. Cancer Biology and Therapy, 8 (1), 66–72 (2009). https://doi.org/10.4161/cbt.8.1.7131 [CrossRef] [PubMed] [Google Scholar]
  • M. Ercolini, B. H. Ladle, E. A. Manning, Recruitment of latent pools of high-avidity CD8+ T cells to the antitumor immune response. Journal of Experimental Medicine, 201 (10), 1591–1602 (2005). https://doi.org/10.1084/jem.20042167 [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.